| scholarly article | Q13442814 |
| P50 | author | Yoshihiro Kawaoka | Q2600945 |
| Kiyoko Iwatsuki-Horimoto | Q66750947 | ||
| Hatice Akarsu | Q73933255 | ||
| Florence Baudin | Q100395020 | ||
| Eiryo Kawakami | Q103806765 | ||
| P2093 | author name string | Takeshi Noda | |
| Taisuke Horimoto | |||
| Hiroaki Katsura | |||
| P2860 | cites work | The gene structure and replication of influenza virus | Q22255660 |
| Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery | Q24534097 | ||
| Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells | Q27469379 | ||
| Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer | Q27629317 | ||
| Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2) | Q27642013 | ||
| Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1 | Q27738409 | ||
| Efficient selection for high-expression transfectants with a novel eukaryotic vector | Q27860810 | ||
| In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein | Q27863692 | ||
| Assembly and budding of influenza virus | Q27863797 | ||
| Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes | Q27864127 | ||
| Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes | Q27865187 | ||
| Molecular assembly of influenza virus: association of the NS2 protein with virion matrix | Q27865315 | ||
| The multifunctional NS1 protein of influenza A viruses | Q28294201 | ||
| Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine | Q28367584 | ||
| Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. | Q28609759 | ||
| Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport | Q28609810 | ||
| Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs | Q28609836 | ||
| Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome | Q28646335 | ||
| Generation of influenza A viruses entirely from cloned cDNAs | Q29616768 | ||
| Large-scale sequence analysis of avian influenza isolates. | Q30352711 | ||
| Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides | Q30452201 | ||
| Association of influenza virus matrix protein with ribonucleoproteins | Q33706147 | ||
| Mutation in NS2, a nonstructural protein of influenza A virus, extragenically causes aberrant replication and expression of the PA gene and leads to generation of defective interfering particles | Q33730979 | ||
| Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins | Q33797502 | ||
| Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape | Q33886239 | ||
| The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins | Q33888022 | ||
| Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein | Q33914921 | ||
| Influenza A virus-generated small RNAs regulate the switch from transcription to replication | Q33953132 | ||
| Engineered RNA viral synthesis of microRNAs | Q33953313 | ||
| Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique | Q34099139 | ||
| The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly | Q34648238 | ||
| Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1 | Q34685189 | ||
| Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein | Q35131981 | ||
| Influenza virus targets the mRNA export machinery and the nuclear pore complex | Q35629429 | ||
| Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs | Q35837862 | ||
| Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks | Q35891622 | ||
| Regulation of eukaryotic protein synthesis: selective influenza viral mRNA translation is mediated by the cellular RNA-binding protein GRSF-1. | Q36378896 | ||
| Influenza virus NS1 protein stimulates translation of the M1 protein. | Q36628590 | ||
| A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity | Q36670254 | ||
| Expression of influenza virus NS2 nonstructural protein in bacteria and localization of NS2 in infected eucaryotic cells. | Q36902228 | ||
| The smallest genome RNA segment of influenza virus contains two genes that may overlap | Q37339406 | ||
| Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence | Q37492701 | ||
| Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes | Q37743549 | ||
| Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. | Q38287598 | ||
| Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation | Q38288951 | ||
| Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus | Q39454971 | ||
| Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway | Q39601251 | ||
| Influenza A virus NEP (NS2 protein) downregulates RNA synthesis of model template RNAs | Q39602853 | ||
| Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. | Q39876368 | ||
| Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions | Q40108978 | ||
| Architecture of ribonucleoprotein complexes in influenza A virus particles | Q40325038 | ||
| The matrix 1 protein of influenza A virus inhibits the transcriptase activity of a model influenza reporter genome in vivo. | Q41008373 | ||
| An amino acid change in the non-structural NS2 protein of an influenza A virus mutant is responsible for the generation of defective interfering (DI) particles by amplifying DI RNAs and suppressing complementary RNA synthesis | Q41500187 | ||
| Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses | Q43756587 | ||
| Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase | Q44539835 | ||
| NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome | Q45386145 | ||
| PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes | Q45707286 | ||
| Influenza virus M1 protein binds to RNA through its nuclear localization signal | Q45761700 | ||
| Structure of influenza virus ribonucleoprotein particles. II. Purified RNA-free influenza virus ribonucleoprotein forms structures that are indistinguishable from the intact influenza virus ribonucleoprotein particles | Q45764537 | ||
| Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor | Q45772727 | ||
| NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells | Q45856468 | ||
| Multiple alignment comparison of the non-structural genes of influenza A viruses | Q47862435 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | attenuated vaccine | Q1810913 |
| influenza A virus | Q834390 | ||
| vaccine engineering | Q14861085 | ||
| P304 | page(s) | 240-248 | |
| P577 | publication date | 2010-10-21 | |
| P1433 | published in | Virus Research | Q15749215 |
| P1476 | title | Structure-based design of NS2 mutants for attenuated influenza A virus vaccines | |
| P478 | volume | 155 |
| Q39355418 | Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells |
| Q30373128 | Current and emerging cell culture manufacturing technologies for influenza vaccines. |
| Q30224970 | Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets |
| Q89998096 | Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine |
| Q41573715 | Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells |
| Q30411859 | New technologies for influenza vaccines |
| Q30354239 | Possibility of cross-species/subtype reassortments in influenza A viruses: an analysis of nonstructural protein variations. |
| Q26863710 | Recent progress in structure-based anti-influenza drug design |
| Q34082989 | Structure-based vaccines provide protection in a mouse model of ehrlichiosis |
| Q30424943 | Vaccine development for protecting swine against influenza virus |
| Q38148782 | Vaccines based on structure-based design provide protection against infectious diseases |
| Q30362529 | Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection. |
Search more.